Tags

, , , , , , , , , , , , , , , , , , , , , , , ,

Hydroxychloroquine and chloroquine are cheap and have a long track record. There was a lot of money for pharmaceutical companies in killing this as treatment for Covid-19. Since pharmaceutical companies are parasites, they probably don’t want us all dead, but have been perfectly willing to kill some of us – whether directly or indirectly.

Both studies involve alleged data from Surgisphere Corporation (“Surgisphere”) owned by Sapan Desai. We don’t know if Sapan Desai is a running dog for one or more pharmaceutical companies, or has family connections or investment in a particular pharmaceutical company.

It must be fun to just make studies and data up. It takes lying with statistics to a new level! Historians also make stuff up sometimes. Why don’t they just write novels? Their English is too poor? The repercussions of the apparently fake data used for the chloroquine paper are both obvious and serious. The other apparent fraud on the impacts of blood pressure medicines is more complicated and potentially very serious. The paper dealing with blood pressure medicine was cited over 500 times in other articles. Were these updated? How many died due to these “apparent” fraudsters? Were they paid by Pfizer-BioNTech or other vaccine makers/pharmaceutical companies? Or did they do it on their own accord.

In a just world, the authors would be fired and banned from ever publishing again, and they and the journals held liable and a class action suit filed against them.

Our opinion of academia and of the medical establishment was already far lower than Joe Biden’s approval rating pre-pandemic anyway! So, it must be Zero Kelvin by now, i.e. minus (−) 459.67 (F).

And, it’s simply more demerit points for our many unneeded immigrants from India. We have always had enough workers and fraudsters and don’t need anymore of either one.

So, yet more upper caste Hindu “apparent” fraudsters. The biggest fraud, however, is upper class/upper caste Hindus coming to the United States and claiming minority status-affirmative action, which was meant for African Americans whose ancestors were enslaved within the United States. This allows them to get government minority contract set asides, etc. In India undercastes (Dalit and Tribal people) and poor get affirmative action, so the elite persecutors come to the USA and pretend to be the persecuted. This crime makes this blogger so enraged, that we rarely are able to finish posts dealing with the topic.😡 Almost no one talks about America’s ever growing upper caste Hindu (Asian-Indian) problem. Most Asian-Indians in the United States are upper caste. Prior to the US Civil Rights laws, there were almost no people from India in the United States. Clearly they were brought in to take affirmative action from African Americans. Unknown numbers go so far as to “pass for” African Americans – taking advantage of the ignorance of Americans. Judge Tanya Chutkan, for instance, is at least half Hindu from Jamaica. We don’t know the other half. Regardless, her ancestors weren’t enslaved within the United States. Nor did they suffer under Jim Crow segregation. The new upper caste Hindu CEO of Twitter has said that he isn’t bound by the First Amendment: https://archive.md/JQ2cu Just because China is a problem, doesn’t mean that India or every Asian-Indian is our friend. We have an increasingly huge problem in the United States with upper caste/upper class immigrants “of color” and their offspring. India is in the Shanghai Cooperation Agreement with China, but no one says anything about it. If anyone says that India is a trusted ally you had better a) question their intelligence and b) follow the money trail. Like in the United States, one administration might be trustworthy and others not. Mehra caste: https://en.wikipedia.org/wiki/Khatri Desai means feudal lord: https://en.wikipedia.org/wiki/Desai
While we can’t be certain that they are still Hindu, we use Hindu, as historically used, to mean from India, because US treaties with Native Americans use the word “Indian”.

Of course, Pete Buttigieg is the offspring of another unneeded immigrant (from Malta). Since ol’ Pete can’t pass for “of color” he’s claiming special privileges because he’s gay.


DOI: 10.1016/S0140-6736(20)31180-6


Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://pubmed.ncbi.nlm.nih.gov/32356626/

US “Sen. Johnson Requests Records from Top Medical Journals Regarding Retracted Studies December 16, 2021
WASHINGTON – On Tuesday, U.S. Sen. Ron Johnson (R-Wis.), ranking member of the Permanent Subcommittee on Investigations, sent letters to The Lancet and the New England Journal of Medicine requesting records regarding last year’s publication and subsequent retraction of studies on COVID-19 that used questionable data. 

The Lancet study, in particular, relied on problematic data to conclude that hydroxychloroquine and chloroquine did not help people with COVID-19.  “Although this fraudulent study was ultimately retracted, it is concerning and shameful that, in the midst of a pandemic, The Lancet published such a misleading paper on a potential early treatment for COVID-19,” the senator wrote.

Both letters are below and can be found here and here. https://www.ronjohnson.senate.gov/services/files/0C198AC9-BCB9-4686-BA02-659D691EF373
https://www.ronjohnson.senate.gov/services/files/34663A2C-54CA-49C1-A41A-A76D814EAF03

December 14, 2021
Dr. Richard Horton
Editor-in-Chief
The Lancet
230 Park Avenue
New York, NY 10169
 
Dear Dr. Horton:

I write to request information regarding the publication and subsequent retraction of a study published in The Lancet titled, “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis” (“the study” or “the paper”).   This study, which first appeared in The Lancet on May 22, 2020, reportedly found that, “treating people who have [COVID-19] with chloroquine and hydroxychloroquine did not help and might have increased the risk of abnormal heart rhythms and death.”

According to reports, following the study’s publication, scientists and clinicians raised concerns about the veracity of the data used in the study. Specifically, experts questioned, “the astonishing number of patients involved and details about their demographics and prescribed dosing[.]”   The Surgisphere Corporation (“Surgisphere”), a Chicago-based company, supplied the dataset that served as the basis for the study. Surgisphere’s owner and founder, Dr. Sapan Desai, was one of the authors of the study.

On June 3, 2020, The Lancet issued an “expression of concern” regarding the study after “serious scientific questions” were brought to the editors’ attention.  

On June 5, 2020, the authors of the study, not including Dr. Desai, published a statement retracting their paper.   Shortly after the retraction, you reportedly called the study a “fabrication” and “a monumental fraud.”
               
Although this fraudulent study was ultimately retracted, it is concerning and shameful that, in the midst of a pandemic, The Lancet published such a misleading paper on a potential early treatment for COVID-19.  In order to better understand The Lancet’s actions regarding this study, I request the following:

1. The preservation of all records  referring or relating to the study titled, “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.”
2. All documents and communications between and among employees or representatives of The Lancet and U.S. government employees referring or relating to the study.
3. All documents and communications between and among The Lancet employees or representatives who reviewed this study, including any comments, ratings, findings and recommendations of the peer reviewers.
4. All documents and communications between and among employees or representatives of The Lancet and individuals or organizations encouraging The Lancet to publish the study.
5. All documents and communications between and among employees or representatives of The Lancet and the study’s authors, or their representatives.
6. All documents and communications between and among employees or representatives of The Lancet and employees or representatives of Surgisphere.

Please provide this information as soon as possible but no later than January 4, 2022.  Thank you for your attention to this matter.

Sincerely,                                                                                    
Ron Johnson
Ranking Member
Permanent Subcommittee on Investigations

December 14, 2021
Dr. Eric Rubin
Editor-in-Chief
New England Journal of Medicine
860 Winter Street
Waltham, MA 02451
 
Dear Dr. Rubin:

I write to request information regarding the publication and subsequent retraction of a study published in the New England Journal of Medicine (“NEJM”) titled, “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19” (“the study” or “the paper”).  

This study, which first appeared in NEJM on May 1, 2020, reportedly found that, “taking certain blood pressure drugs, including angiotensin-converting enzyme (ACE) inhibitors, didn’t appear to increase the risk of death among COVID-19 patients, as some researchers had suggested.”
               
On June 2, 2020, you issued an “expression of concern” regarding the study based on “substantive concerns [that had] been raised about the quality of the information in [the study’s] database.”   The company that had provided the database in question was the Surgisphere Corporation (“Surgisphere”), a Chicago-based company, whose owner and founder, Dr. Sapan Desai, coauthored the study.
               
On June 4, 2020, the authors of the study, including Dr. Desai, published a statement retracting their paper.  

Shortly after the retraction, you reportedly stated, “[w]e shouldn’t have published this.”   Although this questionable study was ultimately retracted, it is concerning and shameful that, in the midst of a pandemic, NEJM published a paper on COVID-19 based on problematic data.  In order to better understand NEJM’s actions regarding this study, I request the following:

1. The preservation of all records  referring or relating to the study titled, “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.”
2. All documents and communications between and among employees or representatives of NEJM and U.S. government employees referring or relating to the study.
3. All documents and communications between and among NEJM employees or representatives who reviewed this study, including any comments, ratings, findings and recommendations of the peer reviewers.
4. All documents and communications between and among employees or representatives of NEJM and individuals or organizations encouraging NEJM to publish the study.
5. All documents and communications between and among employees or representatives of NEJM and the study’s authors, or their representatives.
6. All documents and communications between and among employees or representatives of NEJM and employees or representatives of Surgisphere.
Please provide this information as soon as possible but no later than January 4, 2022.  Thank you for your attention to this matter.

Sincerely,                                                                                     
Ron Johnson
Ranking Member
Permanent Subcommittee on Investigations
 ###
https://www.ronjohnson.senate.gov/2021/12/sen-johnson-requests-records-from-top-medical-journals-regarding-retracted-studies

Gujarat link of controversial US doctor who ‘forced’ WHO quiz Trump’s wonder drug” Friday, June 05, 2020 https://www.counterview.net/2020/06/gujarat-link-of-controversial-us-doctor.html